# BWEL (NCT02750826)

> Breast Cancer WEight Loss Study (BWEL Study)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02750826
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Breast Ductal Carcinoma In Situ; Invasive Breast Carcinoma; Stage II Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Synchronous Bilateral Breast Carcinoma
- Interventions: Health Education Program; Weight Loss Intervention
- Enrollment: 3177
- Primary outcome: Invasive disease-free survival

## Indexed commentary on BWEL so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 18
- YouTube: 10
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=bwel-nct02750826

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02750826", "email": "<work email>"}; the inbox owner confirms by the emailed link.